| titleOfInvention |
modified ns0 cell, methods of producing a recombinant protein, obtaining a mammalian host cell, sanitizing a protein affinity chromatography column and treating a patient suffering from multiple sclerosis, vector, composition, processes for harvesting a recombinant protein from a cell culture and to produce a purified composition of daclizumab, medium, and buffer |
| abstract |
Unmodified Cell, Methods of Producing a Recombinant Protein, Obtaining a Mammalian Host Cell, Sanitizing a Protein Affinity Chromatography Column, and Treating a Patient Suffering from Multiple Sclerosis, Composition, Methods for Harvesting a Recombinant Protein from a cell culture and to produce a purified composition of daclizumab, media, and buffer. The present disclosure relates to daclizumab compositions suitable for subcutaneous administration and methods of manufacture thereof. |